ranitidine has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Amico, EA; Filho, CC; Filho, RK; Freire, BT; Furtado, RHM; Giugliano, RP; Neto, PAL; Nicolau, JC; Pereira, AC; Ramires, JAF; Rocha, TR; Strunz, CMC | 1 |
| Bauersachs, J; Flierl, U; Micka, J; Pförtsch, S; Schäfer, A; Seydelmann, N | 1 |
1 trial(s) available for ranitidine and Coronary Artery Disease
| Article | Year |
|---|---|
Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study.
Topics: Aged; Blood Platelets; Clopidogrel; Coronary Artery Disease; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Ticlopidine | 2016 |
1 other study(ies) available for ranitidine and Coronary Artery Disease
| Article | Year |
|---|---|
The H(2)-receptor antagonist ranitidine interferes with clopidogrel-mediated P2Y(12) inhibition in platelets.
Topics: Aged; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug Interactions; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Platelet Activation; Purinergic P2Y Receptor Antagonists; Ranitidine; Receptors, Purinergic P2Y12; Ticlopidine | 2010 |